Literature DB >> 12819106

Pseudomonas aeruginosa ExoU, a toxin transported by the type III secretion system, kills Saccharomyces cerevisiae.

Shira D P Rabin1, Alan R Hauser.   

Abstract

ExoU, a protein transported by the type III secretion system of Pseudomonas aeruginosa, is an important cytotoxin, though its mechanism of action is unclear. Here we show that the intracellular expression of ExoU is cytotoxic to Saccharomyces cerevisiae. Furthermore, internal amino- and carboxyl-terminal deletions confirmed that regions of ExoU previously shown to be essential for killing mammalian cells were also required for killing yeast cells. These findings indicate that S. cerevisiae is a useful model organism for the study of ExoU.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819106      PMCID: PMC161993          DOI: 10.1128/IAI.71.7.4144-4150.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system.

Authors:  Pierre Cosson; Laurence Zulianello; Olivier Join-Lambert; François Faurisson; Leigh Gebbie; Mohammed Benghezal; Christian Van Delden; Lasta Kocjancic Curty; Thilo Köhler
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

2.  Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.

Authors:  A R Hauser; J N Engel
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa.

Authors:  Alan R Hauser; Enesha Cobb; Maria Bodi; Dolors Mariscal; Jordi Vallés; Joanne N Engel; Jordi Rello
Journal:  Crit Care Med       Date:  2002-03       Impact factor: 7.598

4.  Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.

Authors:  Heather Feltman; Grant Schulert; Salman Khan; Manu Jain; Lance Peterson; Alan R Hauser
Journal:  Microbiology       Date:  2001-10       Impact factor: 2.777

5.  Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.

Authors:  M Allewelt; F T Coleman; M Grout; G P Priebe; G B Pier
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum.

Authors:  Stefan Pukatzki; Richard H Kessin; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

7.  Cloning, expression, purification and characterization of patatin, a novel phospholipase A.

Authors:  H J Hirschberg; J W Simons; N Dekker; M R Egmond
Journal:  Eur J Biochem       Date:  2001-10

8.  Molecular characterization of the patatin multigene family of potato.

Authors:  G A Mignery; C S Pikaard; W D Park
Journal:  Gene       Date:  1988       Impact factor: 3.688

9.  Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits.

Authors:  J P Wiener-Kronish; T Sakuma; I Kudoh; J F Pittet; D Frank; L Dobbs; M L Vasil; M A Matthay
Journal:  J Appl Physiol (1985)       Date:  1993-10

10.  Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury.

Authors:  I Kudoh; J P Wiener-Kronish; S Hashimoto; J F Pittet; D Frank
Journal:  Am J Physiol       Date:  1994-11
View more
  26 in total

Review 1.  Modeling the function of bacterial virulence factors in Saccharomyces cerevisiae.

Authors:  Raphael H Valdivia
Journal:  Eukaryot Cell       Date:  2004-08

Review 2.  Plant perceptions of plant growth-promoting Pseudomonas.

Authors:  Gail M Preston
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

3.  Functional characterization of a phospholipase A(2) homolog from Rickettsia typhi.

Authors:  M Sayeedur Rahman; Nicole C Ammerman; Khandra T Sears; Shane M Ceraul; Abdu F Azad
Journal:  J Bacteriol       Date:  2010-04-30       Impact factor: 3.490

4.  Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.

Authors:  Jeff L Veesenmeyer; Heather Howell; Andrei S Halavaty; Sebastian Ahrens; Wayne F Anderson; Alan R Hauser
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

5.  Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin, ExoU.

Authors:  Hiromi Sato; Jimmy B Feix; Cecilia J Hillard; Dara W Frank
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490

6.  A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.

Authors:  Shira D P Rabin; Jeffrey L Veesenmeyer; Kathryn T Bieging; Alan R Hauser
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2.

Authors:  Izabela Sitkiewicz; Michal J Nagiec; Paul Sumby; Stephanie D Butler; Colette Cywes-Bentley; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

8.  Pseudomonas aeruginosa and sPLA2 IB stimulate ABCA1-mediated phospholipid efflux via ERK-activation of PPARalpha-RXR.

Authors:  Marianna Agassandian; Olga L Miakotina; Matthew Andrews; Satya N Mathur; Rama K Mallampalli
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

9.  Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU.

Authors:  Shira D P Rabin; Alan R Hauser
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

10.  Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU.

Authors:  Gregory H Tyson; Alan R Hauser
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.